Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-8 of 8 for Congenital heart disease in adults

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Safety of BM-MNC Intramyocardial Delivery in Ebstein RV

    Rochester, MN

  2. A Study to Evaluate NT-proBNP Levels in the Prediction of Intrapartum and Postpartum Events in Adult Congenital Heart Disease Patients

    Rochester, MN

  3. A Study to Describe Risk Factor and Clinical Outcomes in Patients with Systemic Right Ventricle

    Rochester, MN

  4. A Study to Assess the Role of Biomarkers in Risk Stratification in Adults with Congenital Heart Disease

    Rochester, MN

  5. Exercise during Heart Cath in CHD Patients

    Rochester, MN

  6. A Study to Evaluate Aortic Dilatation in Patients with Conotruncal Abnormalities

    Rochester, MN

  7. A Study to Describe Risk Factor and Clinical Outcomes in Patients with Left-sided Obstructive Lesions

    Rochester, MN

  8. Stress Echo for Patients with Congenital Heart Disease

    Rochester, MN


Mayo Clinic Footer